All are risk factors for antituberculosis treatment related hepatotoxicity, EXCEPT:: (A) CYP2E1 status, (B) HLA haplotype associations, (C) Female gender, (D) HBeAg negative hepatitis B
Answer is D. Risk factors for antituberculosis treatment related hepatotoxicity are CYP2E1 status HLA haplotype associations Female gender Age > 60 Serum albumin < 3.5 mg/L Pre existing chronic liver disease Multidrug regimens Daily Regimens Excess alcohol consumption Ref: Schiff's diseases of liver, E-11, P-727